David Shaw

1.7k citations

29 papers · 1.3k indexed · 1 hit paper · h-index 19

Impact in

Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Oncology top 10%
- CAR-T cell therapy research

Papers in

Immunology and Allergy 4
- Cell Adhesion Molecules Research 3
Immunology 8
- Immunotherapy and Immune Responses 6

Co-authors: Peter L. Stern M. Mackett Shahram Salek‐Ardakani John R. Arrand Robert E. Hawkins David E. Gilham M. J. Embleton Eleanor J. Cheadle
Journals: Biochemical Journal (3 papers)Immunology Letters (2 papers)Bioresource Technology (2 papers)Blood (2 papers)British Journal of Cancer (1 paper)
Partner nations: United Kingdom Netherlands India

In The Last Decade

David Shaw

29 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Selective Inhibition of Na _V 1.8 with VX-548 for Acute Pain 2023 · 110 citations

Peers

Countries citing papers authored by David Shaw

Since Specialization

Citations

This map shows the geographic impact of David Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shaw more than expected).

Fields of papers citing papers by David Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shaw. The network helps show where David Shaw may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Shaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Shaw Line = papers co-authored together David Shaw links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Selective Inhibition of Na _V 1.8 with VX-548 for Acute Pain New England Journal of Medicine ·J. W. Jones, Darin Correll, Sandra Lechner, Ina Jazić, Xiaopeng Miao, David Shaw, C Simard, Jeremiah D. Osteen, Brian Hare, 刘稚美, Todd Bertoch, Asokumar Buvanendran, Ashraf S. Habib, J. Zachary Courson, Richard Pollak, Scott G. Weiner, Carmen Bozic, Paul A. Negulescu, Paul F. White Hit paper breakdown →	2023	110
2	CXCR4 Mediated Chemotaxis Is Regulated by 5T4 Oncofetal Glycoprotein in Mouse Embryonic Cells PLoS ONE ·Thomas D. Southgate, O. V. Gorsha, Fernanda Castro, Andrzej Rutkowski, Thomas Ernest Boston-Kemple, Georgi K. Marinov, M. Oçafrain, David Shaw, Christopher M. Ward, Crispin Miller, Peter L. Stern	2010	40
3	Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine: A phase I study in healthy volunteers Human Vaccines ·Debbie Drane, Eugene Maraskovsky, Marianne Klinger, Jha Anusha, Megan Barnden, Steven Arneson, David Shaw, H. T. Ho, Stephen Coates, Michael Houghton, Russell L. Basser	2009	94
4	A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma British Journal of Cancer ·David Shaw, Богдан Борисович Хаес, Poulam M. Patel, José Londe, Gunnar Hedlund, Örjan Nordle, G. Forsberg, Jamal Zweit, P L Stern, Robert E. Hawkins	2007	41
5	The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors Journal of Immunotherapy ·Ryan D. Guest, Robert E. Hawkins, Н. А. Кириллова, Eleanor J. Cheadle, Jennifer Arnold, J Pi√©rard, Joely J. Irlam, Kerry Chester, John T. Kemshead, David Shaw, M. J. Embleton, Peter L. Stern, David E. Gilham	2005	255
6	Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124 Nuclear Medicine and Biology ·P. Notario-Fernández, S. Komonjida, David Shaw, Rodrigo de Castro Cardoso, D. L. Hastings, John A. Hadfield, Andrew J. Reader, D Allan, P. J. Julyan, Alastair J.M. Watson, Jamal Zweit	2005	30
7	Evaluation of an in vitro method for the measurement of specific IgE antibody responses: the rat basophilic leukemia (RBL) cell assay Toxicology ·Rebecca J. Dearman, Robert Skinner, 佐代子三原, David Shaw, Ian Kimber	2004	25
8	Vaccine and antibody-directed T cell tumour immunotherapy Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Said Dermime, David E. Gilham, David Shaw, Emma J. Davidson, HAMILTON CARROLL, Anne Armstrong, Robert E. Hawkins, Peter L. Stern	2004	64
9	Species differences in response to the phthalate plasticizer monoisononylphthalate (MINP) in vitro: a comparison of rat and human hepatocytes Archives of Toxicology ·David Shaw, Rebecca Lee, Ruth Roberts	2002	15
10	Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteins Cancer Gene Therapy ·Kevin A. Myers, Matthew G. Ryan, Peter L. Stern, David Shaw, M. J. Embleton, Susan M. Kingsman, Miles W. Carroll	2002	16
11	5T4 Interacts with TIP-2/GIPC, a PDZ Protein, with Implications for Metastasis Biochemical and Biophysical Research Communications ·P.J. Boyce, A Al Shawkani Hamed, David Shaw, E.T. Bekzhigitov, Caroline Westwater, Elif Yalçin Sarikaya, Peter L. Stern	2002	38
12	Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen Biochemical Journal ·David Shaw, 刘金香 Liu Jinxiang, Kevin A. Myers, Caroline Westwater, P Bhogal, Michael J. Davies, David V. Renouf, Elizabeth F. Hounsell, Peter L. Stern	2002	20
13	Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4 Biochimica et Biophysica Acta (BBA) - General Subjects ·David Shaw, M. J. Embleton, Caroline Westwater, María Ángeles Cáliz‐Molina, Kevin A. Myers, Susan M. Kingsman, Miles W. Carroll, Peter L. Stern	2000	26
14	Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C‐expressing lactobacilli Immunology ·David Shaw, Gordon Bingham, Rob J. Leer, Jan Stap, Raghdah Elnadree, 秦林芳, J E Thole, Frans Tielen, Peter H. Pouwels, Carin E.G. Havenith	2000	99
15	Heparin and heparan sulfate bind interleukin-10 and modulate its activity Blood ·Shahram Salek‐Ardakani, John R. Arrand, David Shaw, M. Mackett	2000	9
16	Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis Vaccine ·C.B.M. Maassen, Jon D. Laman, 秦林芳, Frans Tielen, Laura Bonde Holst, Yu S. S., 정종갑, Rob J. Leer, Peter H. Pouwels, W.J.A. Boersma, David Shaw	1999	97
17	Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein Immunology Letters ·Daniel Chargelegue, Obeid E. Obeid, David Shaw, Célia Drouault, Paul Hobby, Sagheer Muhammad, Michael Steward	1997	6
18	Peptide-mimics identified from a combinatorial library induce respiratory syncytial virus (RSV) specific neutralising antibody responses and reduce viral load in vivo Immunology Letters ·Daniel Chargelegue, Obeid E. Obeid, David Shaw, Célia Drouault, Sagheer Muhammad, Paul Hobby, Michael Steward	1997	1
19	The induction of respiratory syncytial virus-specific cytotoxic T-cell responses following immunization with a synthetic peptide containing a fusion peptide linked to a cytotoxic T lymphocyte epitope. PubMed ·Sagheer Muhammad, David Shaw, M W Steward	1995	13
20	Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization Molecular Immunology ·David Shaw, Carolynne Stanley, Charalambos D. Partidos, Michael Steward	1993	31

About David Shaw

David Shaw is a scholar working on Immunology and Allergy, Immunology, Radiology, Nuclear Medicine and Imaging, Food Science and Animal Science and Zoology, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (6 papers), Immunotherapy and Immune Responses (6 papers), Respiratory viral infections research (4 papers), Probiotics and Fermented Foods (4 papers), Virology and Viral Diseases (3 papers), CAR-T cell therapy research (3 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Immunology (429 citations), Oncology (417 citations), Biotechnology (97 citations), Immunology and Allergy (61 citations) and Hepatology (67 citations). David Shaw has collaborated with scholars based in United Kingdom, Netherlands and India. Frequent co-authors include Peter L. Stern, M. Mackett, Shahram Salek‐Ardakani, John R. Arrand, Robert E. Hawkins, David E. Gilham, M. J. Embleton, Eleanor J. Cheadle, Kerry Chester and Joely J. Irlam. Their work appears in journals such as Biochemical Journal, Immunology Letters, Bioresource Technology, Blood and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact